Urine microalbumin and NGAL levels were significantly higher in IUGR compared with control infants (Urine NGAL 29.16 [IQR12.10–49.01] versus 13.36 [IQR 7.04–24.45] ng/mL, p = 0.04; urine NGAL/Creatinine ratio 33.2 [IQR 15.61–58.26] versus 17.69 [IQR 11.24–27.16] ng/mg creatinine, p = 0.04; urine microalbumin 48 [IQR 25–62] versus 26 [IQR 21–35] mg/L, p = 0.01) (Fig. 5). The gene discussed is LCN2; the disease is fetal growth restriction.